Innovation Partnership Services manages licensing of UO innovation, which ranges from monoclonal antibodies to smart phone software. Given the breadth of innovation created at UO, our licenses and industry relationships vary considerably. We try to be flexible in understanding the needs of industry partners and work to create relationships that align expectations and maximize the opportunity for UO innovation to benefit the public.

The University of Oregon is committed to socially responsible licensing, including considering provisions that address unmet needs, especially those of neglected patient populations or geographic areas, with particular attention given to improved therapeutics, diagnostics and agricultural technologies for the developing world. Each licensing situation also involves careful consideration as to what provisions may be included that encourage translation of fundamental research into new products and technologies. Our objective is to optimize the likelihood that new knowledge will be used for the public good, whether locally or globally. The following elements are important considerations in licensing UO innovation:

  • Development of the innovation for society's use and benefit.
  • Sharing financial return in recognition of the contributions made by innovators and the institution, so that resources may be reinvested to fuel the innovation ecosystem.
  • Management of potential conflict of interest.
  • Continued right to publish the results of research.
  • Risk undertaken by company (indemnification).

For more information about IPS practice and philosophy, please contact us. For a look at available innovations, browse the Innovation Catalog.